| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.03. | American Shared Hospital Services verlängert Leasingvertrag mit Orlando Health um sieben Jahre | - | Investing.com Deutsch | ||
| AMERICAN SHARED HOSPITAL SERVICES Aktie jetzt für 0€ handeln | |||||
| 19.03. | AMERICAN SHARED HOSPITAL SERVICES - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | AMERICAN SHARED HOSPITAL SERVICES - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
| 02.01. | Fehlklassifizierung von Schulden: American Shared Hospital Services muss Q3-Bilanz korrigieren | 2 | Investing.com Deutsch | ||
| 02.01. | AMERICAN SHARED HOSPITAL SERVICES - 8-K, Current Report | - | SEC Filings | ||
| 16.12.25 | AMERICAN SHARED HOSPITAL SERVICES - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | AMERICAN SHARED HOSPITAL SERVICES - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11.25 | American Shared Hospital GAAP EPS of $0.00, revenue of $7.17M | 1 | Seeking Alpha | ||
| 13.11.25 | American Shared Hospital Services: Gewinnprognose für Q3 2025 verfehlt, Aktie legt dennoch zu | 2 | Investing.com Deutsch | ||
| 13.11.25 | AMERICAN SHARED HOSPITAL SERVICES - 8-K, Current Report | - | SEC Filings | ||
| 12.11.25 | Earnings Preview For American Shared Hospital | 2 | Benzinga.com | ||
| 13.08.25 | American Shared Hospital Services Reports Second Quarter 2025 Financial Results | 401 | GlobeNewswire (Europe) | Total Revenue Increased 16% Sequentially Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the... ► Artikel lesen | |
| 15.05.25 | American Shared Hospital Services Reports First Quarter 2025 Financial Results | 170 | GlobeNewswire (Europe) | Reports 17% Year over Year First Quarter Revenue Growth Conference Call Scheduled for 12:00 PM ET Today SAN FRANCISCO, May 15, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American:... ► Artikel lesen | |
| 04.04.25 | American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results | 469 | GlobeNewswire (Europe) | Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American:... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BECTON DICKINSON | 135,50 | -0,70 % | Argus cuts Becton Dickinson stock price target on market turbulence | ||
| BOSTON SCIENTIFIC | 60,40 | -1,63 % | Boston Scientific HI-PEITHO Trial Shows EKOS System Superior In Acute Pulmonary Embolism Treatment | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced positive data from the HI-PEITHO global randomized clinical trial evaluating the use of the EKOS Endovascular System in patients... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 143,05 | -1,17 % | ALIGN TECHNOLOGY INC - Schwäche mit Signalcharakter | ||
| BAXTER | 14,350 | -0,91 % | Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update | SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| ELEVANCE HEALTH | 255,70 | +0,16 % | Cantor Fitzgerald reiterates Elevance stock rating with $400 target | ||
| AMN HEALTHCARE SERVICES | 16,700 | +4,38 % | AMN Healthcare Services Inc: AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results | Quarterly revenue of $748 million- GAAP loss of ($0.20)/share and adjusted EPS of $0.22DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 2,300 | -4,96 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| AVANOS MEDICAL | 11,900 | +1,71 % | Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results | Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance
Delivered full-year organic growth of 6% in strategic segments
Expanded... ► Artikel lesen | |
| AXOGEN | 27,200 | +0,74 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| ALPHATEC | 9,524 | +0,85 % | Alphatec Holdings, Inc. and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion | ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment
Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering... ► Artikel lesen | |
| ADDUS HOMECARE | 82,00 | +0,61 % | Addus auf KeyBanc-Forum: Strategisches Wachstum und Compliance im Fokus | ||
| STEREOTAXIS | 1,530 | 0,00 % | Stereotaxis, Inc.: Stereotaxis Reports 2025 Full Year Financial Results | ST. LOUIS, March 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial... ► Artikel lesen | |
| OPTION CARE HEALTH | 23,600 | -2,48 % | Moody's bestätigt Rating für Option Care und hebt Ausblick auf positiv an | ||
| APYX MEDICAL | 3,260 | -0,61 % | Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results | Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System (AYON) to meet strong market demandExpect FY2026 total revenue... ► Artikel lesen |